Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 21Thoracic 3Classical hematology 3Plasma cell 1Other hematologic neoplasm 1NET 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Endocrine 1Breast 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 140Myelodysplastic Syndromes 123Myeloproliferative Disorders 103Leukemia, Myeloid, Acute 99Leukemia 67Precursor Cell Lymphoblastic Leukemia-Lymphoma 53Multiple Myeloma 52Lymphoma 49Primary Myelofibrosis 43Polycythemia Vera 43Leukemia, Lymphocytic, Chronic, B-Cell 40Lymphoma, Non-Hodgkin 39Hodgkin Disease 35Leukemia, Myelomonocytic, Chronic 31Thrombocythemia, Essential 30Leukemia, Myeloid, Chronic-Phase 30Hematologic Neoplasms 29Neoplasms 27Lymphoma, Follicular 27Mastocytosis 26Myelodysplastic-Myeloproliferative Diseases 24Lymphoma, Large B-Cell, Diffuse 23Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 23Leukemia, Myeloid, Accelerated Phase 23Blast Crisis 23Neoplasms, Plasma Cell 22Congenital Abnormalities 22Lymphoma, Mantle-Cell 21Lymphoma, B-Cell, Marginal Zone 21Leukemia, Hairy Cell 21

Interventions

Tinzaparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Intestinal Neoplasms × Myeloid × Clear all
NCT03099031 2019-12-16

PREDICARE

LEO Pharma

Completed
420 enrolled
BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Digestive System Neoplasms, Intestinal Neoplasms, Leukemia, Lung Neoplasms, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Prostatic Neoplasms, Thromboembolism, Urogenital Neoplasms, Vascular Diseases, Colorectal Neoplasms, Hemostatic Disorders, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡